Chair: Rachel Batterham (GBR)
| 10:00 – 10:15 | 150 Years of Lilly Innovations: Where We’ve Been and Where We’re Going in Cardiometabolic Medicine | Rachel Batterham (GBR) |
| 10:15 – 11:45 | Obesity and Type 2 Diabetes: Changing the Course of Cardiometabolic disease | John Wilding (GBR) |
| 11:45 – 12:55 | Expanding Possibilities: The Emerging Role of Oral Therapies in Obesity and Type 2 Diabetes | Deborah Horn (USA) Neil Skolnik (USA) Gian Paolo Fadini (ITA) |
| 12:55 – 14:00 | Lunch break | |
| 14:00 – 15:30 | The Next Frontier: Emerging Mechanisms Redefining Cardiometabolic Care | Timo Mueller (DEU) |
| 15:30 – 16:00 | 150 Years of Innovation: Reflections and the Road Ahead in Cardiometabolic Medicine | Rachel Batterham (GBR) |
- Monday, 28 September 2026
- 10:00 - 16:00 CEST
- London Hall